EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Targeted Therapies in Low-Grade Serous Ovarian Cancers

Anna Gonzalez, Christa I Nagel, Paulina J Haight

Current Treatment Options in Oncology · 2024

DOI: 10.1007/s11864-024-01205-4 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Treatment Options in Oncology, 2024. Verfasst von Anna Gonzalez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Molecular Targeted Therapy, Neoplasm Grading, Cystadenocarcinoma, Serous. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Opinion Statement Low grade serous carcinoma of the ovary has been delineated as a separate entity from its counterpart high grade serous carcinoma of the ovary. Molecular profiling has helped to further characterize this disease process and has led to new and exciting treatment options. Surgery has always been a cornerstone of management both in primary and recurrent disease settings. Chemotherapy has been a long-standing backbone of adjuvant treatment, but its efficacy continues to be questioned. Hormonal therapy for upfront and recurrent disease is an effective treatment option with a high response rate and minimal side effects. Newer therapies including MEK, CDK 4/6, and PI3KCA inhibitors have emerged as exciting options for recurrent disease. Ongoing clinical trials will hopefully lead to additional therapeutic opportunities based on novel biomarkers in this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsMolecular Targeted TherapyNeoplasm GradingCystadenocarcinoma, SerousHumansFemaleTreatment OutcomeCombined Modality TherapyDisease ManagementBiomarkers, TumorNeoplasm StagingClinical Trials as Topic

Stichwörter der Autor:innen

Low-grade serous ovarian cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, M-210 Starling Loving Hall, 320 W. 10th Avenue, C…

Zitieren

APA

Gonzalez, A., Nagel, C. I., & Haight, P. J. (2024). Targeted Therapies in Low-Grade Serous Ovarian Cancers. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-024-01205-4

Vancouver

Gonzalez A, Nagel CI, Haight PJ. Targeted Therapies in Low-Grade Serous Ovarian Cancers. Current Treatment Options in Oncology. 2024. doi:10.1007/s11864-024-01205-4

BibTeX
@article{Gonzalez2024,
  author = {Gonzalez, Anna and Nagel, Christa I and Haight, Paulina J},
  title = {Targeted Therapies in Low-Grade Serous Ovarian Cancers},
  journal = {Current Treatment Options in Oncology},
  year = {2024},
  doi = {10.1007/s11864-024-01205-4}
}
Kostenlos starten →